483
Zolberg CorporationZolberg Corporation – FDA 483, Dec 7, 2023
Record Details
An FDA inspection of Zolberg Corporation, a drug manufacturer in Bancal, Philippines, revealed significant deficiencies in quality control, equipment maintenance, and cleaning procedures. The firm failed to ensure final review and approval of batch records, maintained equipment with visible residues and damaged parts, and lacked proper documentation for cleaning effectiveness verification. These observations indicate a failure to adhere to good manufacturing practices.
View Company Profile
ID · 860dd11f-a061-43fb-bb71-55a8e3c08781
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.